Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles

Drug Information Journal

Volumn 31, Issue 4, 1997, Pages 1255-1271

  Liu, Jen Pei ^a   Ma, Mi Chia ^a   Chow, Shein Chung ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b 206 Carnegie Center   (United States)

Author keywords

Dissolution; Distribution; Hypothesis; Similarity

Indexed keywords

CONFERENCE PAPER; DRUG ABSORPTION; DRUG RESEARCH; DRUG SOLUBILITY; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TABLET FORMULATION;

EID: 0030696078     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100426     Document Type: Conference Paper

References (10)

1. Metzler CM. Bioavailability: A problem in equivalence. Biometrics. 1974;30:309-317.
2. Leeson LJ. In vitro/vivo correlation. Drug Inf J. 1995;29:903-915.
3. Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on dissolution profiles. Pharma Technol. 1996;20:64-74.
4. Tsong Y. Statistical assessment of mean differences between two dissolution data sets. Presented at the 1995 Drug Information Association Dissolution Workshop, Rockville, Maryland.
5. Chow SC, Ki FYC. Statistical comparison between dissolution profiles of drug products. J Biopharma Stat. 1997;7:241-258.
6. USP/NF. The United States Pharmacopeia XXII and the National Formulary XVII. Rockville, Maryland: The United States Pharmacopeial Convention; 1990.
7. Chow SC, Liu JP. Current issues in bioequivalence trials. Drug Inf J. 1995;29:795-804.
8. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker, Inc.; 1992.
9. FDA. Guidance on Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Crossover Design. Rockville, Maryland: Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration; 1992.
10. Serfling RJ. Approximation Theorems of Mathematical Statistics. New York: John Wiley and Sons; 1980.